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Heme oxygenases (HO) catalyze the rate-limiting step of heme degradation. The cytoprotective action of the inducible HO-1
isoform, encoded by theHmox1 gene, is required for host protection against systemic infections. Here we report that upregula-
tion of HO-1 expression in macrophages (M) is strictly required for protection against mycobacterial infection in mice. HO-1-
deficient (Hmox1/) mice are more susceptible to intravenousMycobacterium avium infection, failing to mount a protective
granulomatous response and developing higher pathogen loads, than infected wild-type (Hmox1/) controls. Furthermore,
Hmox1/mice also develop higher pathogen loads and ultimately succumb when challenged with a low-dose aerosol infection
withMycobacterium tuberculosis. The protective effect of HO-1 acts independently of adaptive immunity, as revealed inM.
avium-infectedHmox1/ versusHmox1/ SCIDmice lacking mature B and T cells. In the absence of HO-1, heme accumula-
tion acts as a cytotoxic pro-oxidant in infected M, an effect mimicked by exogenous heme administration toM. avium-infected
wild-type M in vitro or to mice in vivo. In conclusion, HO-1 prevents the cytotoxic effect of heme in M, contributing criti-
cally to host resistance toMycobacterium infection.
Mycobacterial infections remain amajor global burden on so-ciety.Mycobacterium tuberculosis, the causative agent of tu-
berculosis, infects as much as one-third of the world population
and accounts for up to 2 million human deaths per year (1). The
advent of the AIDS epidemic and the introduction of immuno-
suppressive therapies have dramatically increased the number of
individuals at risk of infection not only with M. tuberculosis but
also with other Mycobacterium species, which would otherwise
not cause disease, such as Mycobacterium avium, an ubiquitous
bacterium that acts as an opportunistic pathogen in immunocom-
promised individuals (2).
Given the tropism of mycobacteria toward macrophages
(M), host resistance to infection should operate within this spe-
cific cell compartment to confer protection against infection (3).
In keeping with this notion, known factors in resistance toMyco-
bacterium infection include a series of mechanisms operating in
M, including those regulating lysosome fusion, intracellular iron
availability, and production of antimicrobial peptides or reactive
oxygen and nitrogen species (4, 5). M antimicrobial capacity is
also regulated by cytokines, including tumor necrosis factor
(TNF) produced byM and gamma interferon (IFN-) produced
by natural killer (NK) and T cells (4, 6).
One of the hallmarks ofMycobacterium infection is the forma-
tion of large multicellular structures composed of infected as well
as noninfected M, i.e., granulomas. These confine mycobacteria
within the site of infection, restraining pathogen dissemination to
other organs (7, 8). Granulomas also play a critical role in the
recruitment of effector immune cells, including NK and T cells
that are critical for host resistance to infection. However, at late
(chronic) stages ofMycobacterium infection, granulomas can un-
dergo central necrosis, promoting pathogen dissemination (9)
and causing irreversible tissue damage in the lung, a hallmark of
lethal forms of the disease. On the other hand, studies on the zebra
fish embryomodel of granuloma formation induced byMycobac-
terium marinum suggest that the dynamics of granuloma forma-
tion actually favor the initial expansion and dissemination of my-
cobacterium infection (62).
Programmed cell death of infected M can impact granuloma
integrity and hence host resistance to Mycobacterium infection.
While apoptosis promotes T cell cross-priming and as such re-
strainsMycobacterium growth, necrosis is used bymycobacteria to
evade adaptive immunity and promote bacterial growth (10). This
suggests that cytoprotective mechanisms that prevent M necro-
sis, but not apoptosis, should favor granuloma integrity and as
such limitMycobacterium growth (11). We hypothesized that the
cytoprotective enzyme heme oxygenase-1 (HO-1) (12, 13) might
play such a role when expressed by infected M.
Recognition of pathogen-associatedmolecular patterns byM
is associated with the induction of HO-1 expression, which ca-
tabolizes free heme into biliverdin, iron, and the gasotransmitter
carbon monoxide (14). The cytoprotective action of HO-1 (re-
viewed in reference 15) confers host protection against systemic
infections in mice, as demonstrated for malaria (16–18) or severe
sepsis (19). The protective effect of HO-1 against systemic infec-
tions relies to a large extent on its ability to negate the cytotoxic
effects of free heme, that is, heme released from hemoproteins
such as hemoglobin or myoglobin (18, 19; reviewed in reference
15). In the context of severemalaria or sepsis, this protective effect
acts without regard to pathogen load to promote host survival
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(16–19) and as such is said to confer disease tolerance (3). Here we
demonstrate that the cytoprotective effect of HO-1, when exerted
in M, is essential to ensure granuloma integrity and to confer
resistance, rather than tolerance, to mycobacterial infections.
MATERIALS AND METHODS
Ethics statement. This study was carried out in strict accordance with the
recommendations of the European Convention for the Protection of Ver-
tebrate Animals used for Experimental and Other Scientific Purposes
(ETS 123) and Directive 86/609/EEC and Portuguese rules (DL 129/92).
The animal experimental protocols were approved by the competent na-
tional authority, Direcção Geral de Veterinária (DGV) (protocol permit
numbers 520/000/000/2006 and 0420/000/000/2011). All animal experi-
ments were planned in order to minimize mouse suffering.
Mice. We generated Hmox1/ mice by mating Hmox1/ mice, as
previously described (20).Micewere bred at the pathogen-free facilities of
the Instituto Gulbenkian de Ciência (IGC), housed at the Institute for
Molecular and Cell Biology (IBMC) animal facility in high-efficiency par-
ticulate air (HEPA) filter-bearing cages, and fed sterilized food and water
ad libitum. Genomic DNA was isolated from the tail, and the Hmox1
genotype was determined by PCR using the primers 5=-TCTTGACGAGTT
CTTCTGAG-3= with 5=-ACGAAGTGACGCCATCTGT-3= and 5=-GGT
GACAGAAGAGGCTAAG-3= with 5=-CTGTAACTCCACCTCCAAC-3=.
Bacteria. Mycobacterium avium strain 2447, forming smooth trans-
parent (SmT) colonies, was isolated from an AIDS patient and was a gift
from F. Portaels (Institute of TropicalMedicine, Antwerp, Belgium).My-
cobacteria were grown to mid-log phase in Middlebrook 7H9 medium
(Difco) containing 0.05% Tween 80 (Sigma) at 37°C. Bacteria were har-
vested by centrifugation, suspended in a small volume of saline containing
0.05% Tween 80, briefly sonicated to disrupt bacterial clumps, diluted,
and stored in aliquots at 80°C until use. M. tuberculosis strain H37Rv,
kindly provided by António Gil Castro (Life and Health Science Research
Institute, Universidade do Minho, Portugal), was grown in Proskauer-
Beckmedium containing 0.05%Tween 80 tomid-log phase, harvested by
centrifugation, and frozen at80°C until use.
Mouse infection and quantification of bacterial loads in organs.
Mice were infected with M. avium intravenously (i.v.), through a lateral
tail vein, with 106 CFU. Control animals received the same volume of
saline. Mice were infected withM. tuberculosis via the aerosol route, using
an airborne infection apparatus (Glas-Col Inc., Terre Haute, IN), result-
ing in the implantation, on average, of 30 bacilli in the lung of eachmouse.
At different time points, mice were sacrificed, and organs were aseptically
collected and homogenized in a 0.05% Tween 80 solution in distilled
water. Serial dilutions were plated intoMiddlebrook 7H10 (M. avium) or
7H11 (M. tuberculosis) agarmedium (Gibco), the plates were incubated at
37°C for 1 week or 3 weeks, respectively, and the number of colonies was
counted.
Gene expression analysis.Tissue samples were collected and frozen at
80°C until use. Total RNA was extracted using the Micro-to-Midi total
RNA purification system (Invitrogen) according to the manufacturer’s
specifications. Two micrograms of total RNA was transcribed into cDNA
with Moloney murine leukemia virus reverse transcriptase (Fermentas),
using an oligo(dT)18 primer. The primers used for amplification of cDNA
were as follows: hprt1 (housekeeping), 5=-GTAATGATCAGTCAACGGG
GGAC-3= (forward) and 5=-CCAGCAAGCTTGCAACCTTAACCA-3=
(reverse); hmox1, 5=-GCCACCAAGGAGGTACACAT-3= (forward) and
5=-GCTTGTTGCGCTCTATCTCC-3= (reverse). The primers were
shown not to coamplify genomic DNA. All reactions were performed in a
total reaction volume of 20 l with iQ SYBR Green Supermix (Bio-Rad)
and carried out in the iQ5 instrument (Bio-Rad). Baseline thresholdswere
calculated by the Bio-Rad iQ5 program, and the threshold cycles (CT)
were used in theREST software (21), whereCT values for target geneswere
normalized to expression levels of hprt1. Values are reported as fold dif-
ference relative to those for the control samples.
Western blot. Tissue samples were homogenized in radioimmuno-
precipitation assay (RIPA) buffer (50 mM Tris-HCl [pH 8.0], 150 mM
sodium chloride, 1% Igepal, 0.5% sodiumdeoxycholate, 0.1%SDS, 1mM
EDTA) containing protease inhibitors (Sigma). Fifty micrograms of liver
or 20g of spleen in electrophoresis sample buffer (50mMTris-HCl [pH
8.8], 2%SDS, 0.017%bromophenol blue, 10%glycerol, 2mMEDTA, 100
mMdithiothreitol [DTT])was subjected to electrophoresis in a 10%SDS-
polyacrylamide gel and transferred to a 0.45-m nitrocellulose mem-
brane (Amersham Biosciences). The membrane was blocked with 5%
fat-free milk and incubated with rabbit anti-HO-1 antibody (Ab) (Pro-
teintech) or rabbit anti--actin (Abcam), followed by a horseradish per-
oxidase-conjugated sheep anti-rabbit IgG (The Binding Site). Immuno-
reactivity was visualized using an enhanced chemiluminescence (ECL)
reagent (Pierce) according to the manufacturer’s instructions, and the
signal was recorded on a ChemiDoc XRS system (Bio-Rad). Band densi-
tometry was performed with the Quantity One program (Bio-Rad).
Histopathology. Samples of liver or lung were fixed with 4% parafor-
maldehyde in phosphate-buffered saline (PBS) and embedded in paraffin.
Five-micrometer sections were stained with hematoxylin-eosin and the
Masson-trichrome method using standard procedures. For immunoflu-
orescence staining, slides were deparaffinized in Histoclear (National Di-
agnostics) and hydrated by passage through a grade of alcohols. Tissues
were blocked with 4% bovine serum albumin (BSA) in PBS 0.05% Tween
and incubated with purified Abs (rabbit anti-HO-1 [Proteintech] and rat
anti-F4/80 [Serotec]) followed by secondary Abs (anti-rabbit IgG Alexa
Fluor 568 and anti-rat IgGAlexa Fluor 634, both fromMolecular Probes).
Slides were analyzed in a Leica TCS SP2AOBS confocalmicroscope (Leica
Microsystems). Fragmented DNA was detected through terminal de-
oxynucleotidyltransferase-mediated dUTP-biotin nick end labeling
(TUNEL) staining, according to themanufacturer’s instructions (Roche).
Slides were analyzed in a Zeiss AxioSkop wide-field microscope (Carl
Zeiss, Germany). HO-1 was also detected by immunohistochemistry, us-
ing the Impress anti-rabbit Ig reagent (Vector). 8-OHdG was detected by
immunohistochemistry using a monoclonal antibody (clone E2E; Trevi-
genUSA) and the M.O.M. immunodetection kit (Vector), according to
the manufacturer’s instructions.
Detection of cytokines in plasma and tissues. Blood was harvested
into EDTA tubes from mice anesthetized with isoflurane (Abbott Labo-
ratories) by retro-orbital bleeding. The plasma was collected after centrif-
ugation and frozen at80°C until use. At the time of sacrifice, portions of
the organs were stored at80°C. Later, these portions were homogenized
and protein extracts were prepared according to Bio-Rad’s Bio-Plex rec-
ommended protocol. Cytokines were measured with the Bio-Plex multi-
plex cytokine assay system fromBio-Rad, according to themanufacturer’s
instructions. Total protein content was determined in parallel. Data anal-
ysis was performed with Bio-Plex Manager software (Bio-Rad).
Detection of plasma hemoglobin and heme. Plasma hemoglobin was
determined by spectroscopy at  577 nm. Total plasma heme was mea-
sured with the 3,3=,5,5= tetramethylbenzidine (TMB) peroxidase assay
(BD Bioscience) at   655 nm. Purified hemoglobin was used as a stan-
dard for hemoglobin and heme measurements.
Tissue iron measurements. Tissue samples were weighed and des-
iccated in a microwave oven (MDS-2000). The dried samples were
weighed and mineralized by acid digestion and heating at 65°C for 20
h. The sample supernatant was collected, and iron was complexed to
the bathophenantroline sulfonate chromogen as described by Tor-
rence and Bothwell (22). The nonheme iron concentration was mea-
sured spectrophotometrically at   535 nm. Iron content in tissues
was expressed as micrograms of nonheme iron per gram of dry tissue.
Protoporphyrins.Heme (Frontier Scientific Inc.) was dissolved in 0.2
MNaOH, the pHwas adjusted to 7.4 with 0.1MHCl, and the volumewas
completed with distilled water. The solution was then filter sterilized and
stored protected from light at80°C until use.Mice received 0.2ml of the
heme solution every other day by a lateral tail vein, starting 1 day before
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the infection with M. avium. Control mice received an equal volume of
vehicle.
Cell culture. Bone marrow-derived M (BMM) were obtained by
culturing bonemarrow cells that were flushed from the femurs of themice
with Hanks’ balanced salt solution (HBSS) (Gibco). The resulting cell
suspensionwas centrifuged and the cells resuspended inDulbecco’smod-
ified essential medium (DMEM) (Gibco) supplemented with 10mM glu-
tamine, 10 mMHEPES, 1 mM sodium pyruvate, 10% fetal bovine serum
(FBS) (Gibco), and 10% L929 cell-conditioned medium (LCCM) as a
source of macrophage colony-stimulating factor (M-CSF). To remove
fibroblasts, the cells were cultured overnight, at 37°C in a 7% CO2 atmo-
sphere on cell culture dishes. The nonadherent cells were collected with
warm HBSS, distributed in 24-well plates (5 	 105 cells/well) or 96-well
plates (1 	 105 cells/well), and incubated at 37°C in a 7% CO2 atmo-
sphere. After 3 days, 10% LCCM was added. On day 7, the medium was
renewed. On day 10, when the cells were fully differentiated intoM, they
were infected withM. avium, with 106 CFU ofM. avium (24-well plates)
or 2	 105 CFU (96-well plates) added to each well. Cells were incubated
for 4 h at 37°C in a CO2 atmosphere and then washed with warmHBSS to
remove noninternalized bacteria and reincubated in DMEM with 10%
FBS and 10% LCCM. To quantify the mycobacteria, M from triplicate
wells were lysed at different time points with 0.1% saponin (Sigma). Serial
dilutions were plated into Middlebrook 7H10 agar medium, and the
plates were incubated at 37°C for 1 week, when the colonies were counted.
For cytotoxicity assays, BMM were washed with HBSS and exposed to
heme diluted in HBSS for 1 h. After the removal of heme, the cells were
infected with M. avium as described above, and 24 h later, resazurin
(Sigma) was added to the wells (125 M) and incubated at 37°C for 3 h.
The conversion of resazurin to the highly fluorescent resorufin by viable
cells was evaluated by measuring the relative fluorescence units (RFU) in
a SpectraMAX GeminiXS instrument (Molecular Devices).
Statistical analysis. Statistically significant differences between
groups were determined using the unpaired Student t test. Significance is
indicated as follows: *, P
 0.05; **, P
 0.01; and ***, P
 0.001.
RESULTS
M.avium infection is associatedwith inductionofHO-1 expres-
sion in M. Expression of HO-1 supports the viability of acti-
vated M (23, 24), a cell type that is critically involved in provid-
ing host resistance to mycobacterial infections (5). Therefore, we
investigated whether M. avium infection modulates the expres-
sion of HO-1. We found that M. avium infection was associated
with the induction of HO-1 in the livers of BALB/c mice, with the
highest levels of expression at day 30 postinfection, i.e., 5.2 2.7-
and 9.4 5.8-fold increases at the mRNA and protein levels ver-
sus noninfected controls, respectively (Fig. 1A). HO-1 expression
in the liver was restricted to F4/80M, as assessed by immuno-
fluorescence (Fig. 1B). Expression of HO-1 in the spleen was not
significantly induced in response to M. avium infection (see Fig.
S1 in the supplemental material). This was not unexpected, as the
basal level of HO-1 expression in this organ is very high due to its
function in erythrocyte recycling.
HO-1 confers resistance to M. avium infection. To assess
whether host resistance toM.avium infection operates via amech-
anism involving HO-1, we used a loss-of-function approach,
comparing the outcomes of M. avium infection in wild-type
(Hmox1/) versus heterozygous (Hmox1/) or Hmox1-defi-
cient (Hmox1/) BALB/cmice (20). The bacterial loadwas about
100-fold higher inHmox1/ than inHmox1/mice, as assessed
in the liver, spleen, and lungs, at 60 days postinfection (Fig. 1D).
This reveals that host resistance to M. avium relies on a mecha-
nism involving the expression of HO-1, presumably in M. The
bacterial load in heterozygous (Hmox1/) mice was similar to
that in wild-type (Hmox1/) mice (Fig. 1D).
Given that host resistance toMycobacterium infection relies on
interleukin-12 (IL-12)-driven IFN--production by CD4 T
helper (TH) cells (25), we asked whether impaired resistance toM.
avium infection in Hmox1-deficient mice is associated with inhi-
FIG 1 Expression of HO-1 is required for host resistance to M. avium infec-
tion. BALB/c mice were infected Mycobacterium avium 2447 SmT (106 CFU,
i.v.). (A) Expression of HO-1 protein in the liver, detected byWestern blotting
at 1, 15, 30, and 60 days after infection. (B)Hmox1mRNA expression quanti-
fied by quantitative reverse transcription-PCR (qRT-PCR) in the livers of
BALB/cmice and densitometry of theWestern blot shown in panel A. Data are
shown as fold change in infected relative to noninfected mice (dashed line)
(n 3 to 5 mice per time point). (C) HO-1 expression detected by immuno-
fluorescence in a representative liver section fromBALB/cmice at 30 days after
M. avium infection. Arrows indicate F4/80 cells expressing HO-1. (D) Bac-
terial loads in the livers, spleens, and lungs of M. avium-infected Hmox1/,
Hmox1/, andHmox1/ BALB/c (n 3 per genotype) or SCID (n 4 or 5
per genotype) mice. Bars represents mean standard deviation of log10 CFU/
organ. *, P
 0.05; ***, P
 0.001; NS, not significant.
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bition of this antimicrobial response. To test this hypothesis, we
compared the outcomes ofM. avium infection inHmox1/mice
and Hmox1/ BALB/cscid (SCID) mice lacking peripheral T and
B cells. As expected (26), SCID mice were more permissive toM.
avium growth than immunocompetentmice, as revealed by a 5- to
10-fold increase in bacterial load (Fig. 1D). The bacterial load was
about 100-fold higher in Hmox1/ than in Hmox1/ SCID
mice, revealing that the mechanism via which HO-1 contributes
to host resistance toM. avium acts independently of adaptive im-
munity (Fig. 1D). This increase in bacterial growth in different
organs of Hmox1/ mice was also observed at earlier infection
time points, namely, at 15 and 30 days of infection (see Fig. S2A in
the supplemental material).
Given that induction of HO-1 expression in response to M.
avium infection is restricted to M (Fig. 1C), we compared the
capacities of M derived from the bone marrow of wild-type and
Hmox1-deficient mice to controlM. avium growth in vitro. There
was no difference in M. avium growth in Hmox1/ and
Hmox1/M, as assessed at 4 or 7 days after infection (see Table
S1 in the supplemental material). This suggests that HO-1 con-
trolsM. avium growth in vivo via a mechanism that is not driven
by a cell intrinsic effect of this enzyme on bacterial growth within
M, as suggested by data obtained in vitro for Mycobacterium
tuberculosis (27, 28).
The protective effect of HO-1 againstMycobacterium infec-
tion acts independently of the regulation of key cytokines. Re-
sistance to Mycobacterium infection relies on the production of
several proinflammatory cytokines (26, 29), while anti-inflamma-
tory cytokines, e.g., IL-10, can increase host susceptibility (30). To
assess whether enhanced susceptibility of Hmox1-deficient mice
to M. avium infection was associated with deregulated cytokine
production, the concentrations of several cytokines functionally
involved in host protection againstM. avium infection were com-
pared in the plasma, liver, and spleen of infectedHmox1/ versus
Hmox1/ SCID mice. Expression of IFN-, TNF, IL-17, and
IL-10 was similar in Hmox1/ and Hmox1/ SCID mice, as
assessed at 30 days postinfection (Fig. 2). Expression of IL-12p40
was higher in infectedHmox1/mice than in wild-type controls
(Fig. 2), which is at first inconsistent with the impaired resistance
of Hmox1/ mice to M. avium infection (Fig. 2). Expression of
IL-1 and IL-6was also higher in the spleen (but not in the plasma
or liver) of infected Hmox1/ versus Hmox1/ mice (Fig. 2).
This indicates that the protective effect of HO-1 againstM. avium
infection acts via a mechanism that is probably not based on the
regulation of cytokines involved in bacterial clearance, such as
IL-12, TNF, IFN-, or IL-10 (29), instead being associated with a
downregulation of the proinflammatory cytokines IL-1 and
IL-6.
Expression of several chemokines functionally involved in host
protection against Mycobacterium infection (31) was also com-
pared in Hmox1/ and Hmox1/mice, 30 days afterM. avium
infection. The MCP-1/CCL2 concentration in plasma, liver, and
spleen was higher in Hmox1/ than in Hmox1/mice (Fig. 2),
which is in keeping with a recent report suggesting that HO-1
controlsMCP-1/CCL2 duringMycobacterium infection (32). This
was also the case for CCL3, but only in the spleen (Fig. 2). Expres-
sion of CCL4 was similar inHmox1/ andHmox1/mice (Fig.
2). Similar results were observed at 15 days of infection (see Fig.
S2B in the supplemental material). Hmox1-deficient mice also
showed higher hepatic expression of IL-12p40, Ccl2, Ccl5, and
Icam-1 mRNAs thanHmox1/mice (see Fig. S2C in the supple-
mental material).
Hmox1-deficient mice lack granulomas and develop tissue
damage in response toM. avium infection. To gain further un-
FIG 2 Hmox1-deficient mice produce normal or elevated levels of inflammatory cytokines and chemokines in response to M. avium infection. Cytokine and
chemokine concentrations in the plasma, livers, and spleens of SCID.BALB/cHmox1/ andHmox1/mice at 30 days afterM. avium infection were assessed
by a bead-based multiplex immune assay. Data are shown as mean standard deviation for a group of 3 mice per genotype. *, P
 0.05; **, P
 0.01; ***, P

0.001.
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derstanding of the mechanisms underlying the susceptibility of
Hmox1-deficient mice to Mycobacterium infection, histological
analysis of the livers ofM. avium-infectedmice was performed. As
expected (33), intravenousM. avium inoculation induced the for-
mation of granulomas in the livers of wild-type BALB/c mice.
These multicellular structures are composed of a core of epitheli-
oid M surrounded by a lymphocytic cuff (Fig. 3A and B), with
accumulation of collagen fibers (Fig. 3C). Granulomas were ab-
sent in Hmox1/ mice (Fig. 3D to F). Although collagen fibers
were detected in the liver, these were dispersed without apparent
organization (Fig. 3F). Likewise, leukocyte infiltrates, composed
mostly of granulocytes, were observed, but without granuloma-
like organization (Fig. 3D and E). Several alterations in the overall
architecture of the liver parenchyma were found in infected
Hmox1-deficient versus wild-type mice. These include extensive
vascular damage associated with smooth muscle cell proliferation
(Fig. 3D), collagen deposition (Fig. 3F), and enlarged sinusoids
and extensive cell infiltrations (Fig. 3E). Noninfected age-
matched Hmox1-deficient mice did not show significant patho-
logical alterations compared to wild-type controls (see Fig. S3A
andE in the supplementalmaterial). Similar pathological features,
including the absence of granulomas, were also observed in M.
avium-infectedHmox1/ versusHmox1/ SCIDmice (see Fig.
S3B to D and F to H in the supplemental material). This demon-
strates that expression of HO-1 is required for granuloma forma-
tion and/or maintenance, independently of any effect on T or B
lymphocytes.
When infected with M. avium, Hmox1/ mice had twice as
much iron accumulation in the liver as did wild-type mice (Fig.
4A). Moreover, Hmox1/mice accumulated cell-free hemoglo-
bin andheme in plasma at levels thatwere 4-fold higher than those
in wild-type mice (Fig. 4A). Given that heme and labile iron can
act in a pro-oxidant manner during systemic infections (34), we
asked whether infected Hmox1/ developed oxidative stress,
presumably leading to programmed cell death and tissue damage.
We found that this is the case, as revealed by the higher accumu-
lation of oxidized guanine in the livers of infectedHmox1/ ver-
sus Hmox1/ mice, a hallmark of oxidative stress-induced nu-
cleic acid damage (Fig. 4B).
Heme causes oxidative stress leading to programmed cell death
in response to several agonists, including TNF (18). In the case of
M, heme promotes TNF-mediated necroptosis (24), a pro-
grammed form of necrosis (35). To investigate whether M pro-
grammed cell death occurs duringM. avium infection in vivo, we
detected cell death by TUNEL assay in the livers of infected mice.
We found that M. avium infection was associated with increased
cell death in Hmox1/ versus Hmox1/ mice (Fig. 5A and C).
We did not find a corresponding increase in cleaved caspase-3-
positive cells (Fig. 5B and C), which is consistent with the notion,
although does not prove, that cells are dying by necroptosis (24,
35, 36). This increased cell death in the tissues ofHmox1/mice
is observed as soon as 15 days after infection (see Fig. S2D in the
supplemental material). We conclude that expression of HO-1,
presumably in M, acts in a cytoprotective manner to prevent
programmed cell death duringM. avium infection.
Heme induces infected M to undergo programmed cell
death and impairs granuloma formation. Given the results pre-
sented above, we reasoned that heme might sensitize mycobacte-
rium-infected M to undergo programmed cell death (24), com-
promising granuloma formation and ultimately host resistance to
infection. To test this hypothesis, we exposed bone marrow-de-
rived M to heme before M. avium infection in vitro. Heme-
treatedM underwent programmed cell death, as assessed at 24 h
after infection (Fig. 6A and B). This effect was dose dependent in
that increasing the heme concentration progressively reducedM
FIG 3 Hmox1-deficient mice do not form granulomas. Liver sections from
BALB/c Hmox1/ (A, B, and C) and Hmox1/ (D, E, and F) mice stained
with hematoxylin and eosin (A, B, D, and E) or Masson’s trichrome (collagen
fibers stain blue) (C and F) at 60 days after M. avium infection are shown.
Arrows indicate granulomas. Bar, 100 m. Notice the lack of granulomas in
Hmox1-deficient mice (D to F) versus wild-type controls (A to C).
FIG 4 Hmox1-deficient mice develop oxidative stress. (A) Quantification of
hemoglobin and free heme in the plasma and total iron in the livers of BALB/c
Hmox1/ andHmox1/mice at 60 days afterM. avium infection (n 3 to
5). Bars represent the average standard deviation for each group. *,P
 0.05;
**, P
 0.01. (B) Oxidative stress in the livers of BALB/c mice was monitored
by detecting oxidized nucleosides 8-OHdG and 8-OHG, which are markers of
oxidative damage to DNA and RNA, respectively, by immunohistochemistry.
Note the increased DAB (brown) straining in the cytoplasm (RNA) and nuclei
(DNA, arrows) of Hmox1/ mice. The sections were counterstained with
methyl green. Bar 50 m.
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viability (Fig. 6B). Concomitantly with heme-induced cell death,
M became more permissive to mycobacterial proliferation (Fig.
6C). Despite the increased growth of mycobacteria in heme-
treated M, heme was equally efficient at inducing cell death in
uninfected and infectedM (Fig. 6B), suggesting that necroptosis
is induced not by higher pathogen loads but by the pro-oxidant
effect of heme. These results further suggest that heme impairs the
bactericidal activity of M, compromising host resistance to my-
cobacterial infection.
On the other hand, the in vivo administration of heme to M.
avium-infected BALB/c mice inhibited granuloma formation
(Fig. 6D and F). This was, however, not associated with the detec-
tion of cell death in the liver or the increase in bacterial load, as
assessed at 15 days after infection (Fig. 6E). This suggests that
heme suppresses granuloma formation at an early stage of infec-
tion, rather than disrupting preformed granulomas.
Host resistance toM. tuberculosis infection acts via a mech-
anism that requires the expression of HO-1. Unlike M. avium,
Mycobacterium tuberculosis actively manipulates the death pathway
of its host cells (10). Therefore,we askedwhether expressionofHO-1
is also required toconferhost resistance toM.tuberculosis infection. It
was previously reported that intravenous infection with high doses
(105 and 106 CFU) ofM. tuberculosis induces the expression ofHO-1
in the lung (27, 28). Here, we used a model of infection with a low
dose ofM. tuberculosis (30 CFU) via the aerosol route, which more
closely replicates the natural route of infection.After 60 days of infec-
tion, we detected the expression of HO-1 by immunohistochemistry
in the lung. Akin to the case for M. avium, HO-1 was induced in
granulomas, while it is absent from healthy tissue (Fig. 7A). In the
absence of HO-1, mice developed higher bacterial loads in the lung
FIG5 Hmox1-deficientmice have increased cell death. (A and B) Cell death in
the livers of BALB/cHmox1/ andHmox1/mice was evaluated by TUNEL
(green) (A) and by detecting cleaved caspase-3 (red) (B) at 60 days after M.
avium infection. Nuclei were stained with DAPI (blue). Bar, 100 m. (C)
Quantification of the positive cells in panels A and B. Bars represent the aver-
age standard deviation for each group. *, P
 0.05; ***, P
 0.001.
FIG 6 Heme administration triggers M cell death and hampers granuloma
formation. Bone marrow-derived M (BMM) from wild-type mice were
exposed to heme 1 h prior to M. avium infection. (A) Cell death of BMM
visualized byTUNEL (green) at 24 h afterM. avium infection.DAPI (blue)was
used for total DNA staining. (B) BMM viability was quantified by resazurin
staining at 24 h after M. avium infection. Results are shown as mean  stan-
dard deviation for three culture wells per condition. (C) Bacterial load was
quantified at 4 days after infection as CFU. Results are shown as mean 
standard deviation of the log10 increase in CFU/well of three wells per condi-
tion. *, P 
 0.05; ***, P 
 0.001. (D) Number of granulomas in the livers of
BALB/cmice treatedwith heme (40mg/kg, every other day, i.v.) or vehicle and
infected with M. avium for 16 days. Each bar represents the mean  one
standard deviation (n 3). *,P
 0.05. (E) Bacterial loads in the livers, spleens,
and lungs of the mice described for panel D. Each bar represents the mean
one standard deviation of log10 CFU/organ. (F) Representative images of he-
matoxylin- and eosin-stained liver sections. Arrows indicate granulomas. The
inset shows one typical granuloma. Bar, 100 m.
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and spleen than wild-type mice at 60 days postinfection (Fig. 7B).
Furthermore, all Hmox1/ mice succumbed to M. tuberculosis in-
fection,whilewild-type (Hmox1/) andheterozygous (Hmox1/)
mice all survived until day 240 postinfection, the last time point ana-
lyzed (Fig. 7C). The lung bacterial load at the time of death of
Hmox1/mice ranged from 5.1 to 8.6 log10 CFU (Fig. 7C, values in
brackets), compared to 3.4 to 4.3 log10CFU inHmox1
/mice at the
same time range after infection. When infected withM. tuberculosis,
Hmox1/mice also exhibitedhigher bacterial loads in other organs.
At the time of death, the bacterial load of these mice ranged from
5.4 to 8.4 log10 CFU in the spleen and from 5.2 to 8.5 log10 CFU in
the liver, while wild-type mice presented 4.1 to 4.3 log10 CFU in the
spleen and below the level of detection (below 100 bacteria) in the
liver at the same timeof infection.Histological analysis of the lungsof
Hmox1/mice at 60days afterM. tuberculosis infection showed rare
lesions, composed predominantly of lymphocytes, surrounding a
central M core and corresponding to early-stage granulomas (Fig.
7D). Cell infiltrates were also observed in M. tuberculosis-infected
Hmox1/ mice, but these were composed predominantly of M
and appeared to be less organized (Fig. 7D). Lung sections from
Hmox1-deficient mice also showed high bacterial loads in this organ
(Fig. 7E) and significantly increased levels of cell death, revealed by
TUNEL staining (Fig. 7F). Overall, these observations reveal that ex-
pression of HO-1 also plays a critical role in controllingM. tubercu-
losis infection in the lung.
DISCUSSION
The present work shows that HO-1 plays a central role in the
control of Mycobacterium infection. This heme-catabolizing en-
zyme is required to confer host resistance toMycobacterium infec-
FIG 7 Expression of HO-1 is required for host resistance toM. tuberculosis infection. (A) The expression of HO-1 was detected by immunohistochemistry in the
lungs of BALB/c mice infected aerogenically with a low dose (30 CFU/mouse) ofM. tuberculosis for 2 months. Note the expression of HO-1 (brown) within the
granuloma. Bar, 200 m. (B) Bacterial loads in the lungs and spleens of BALB/c mice infected aerogenically with a low dose (30 CFU/mouse) ofM. tuberculosis
for 2 months. *, P 
 0.05; **, P 
 0.01. Each symbol indicates an individual mouse analyzed, and horizontal bars indicate mean values. (C) Survival of M.
tuberculosis-infected mice. Values in brackets indicate the log10 CFU in the lungs of moribund mice.Hmox1
/, n 5;Hmox1/, n 4; andHmox1/, n
5. (D) Representative lung sections stained with hematoxylin and eosin from infected wild-type (left) and Hmox1/ (right) mice at 60 days after infection.
Notice the granuloma in formation in the wild-type mouse and the monocytic, less organized infiltrate in the Hmox1/ mouse. (E) Representative Ziehl-
Neelsen staining of the lung of amoribundHmox1/mouse (bar, 50m). (F) Representative TUNEL staining of the lung of anHmox1/mouse infectedwith
M. tuberculosis for 2 months.
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tion, acting via mechanisms that are independent of the classic
IL-12–IFN- axis and the development of protective pathogen-
specific T cells (Fig. 1D) (26, 29, 37). Instead, HO-1 is required to
sustain M viability during infection (Fig. 5 and 6) and for the
formation and/or maintenance of protective granulomas (Fig. 3).
Mechanisms regulating M viability can have a major impact
on the outcomeofMycobacterium infections (10).Nonpathogenic
mycobacterial species and attenuated strains of M. tuberculosis
induceM to undergo apoptosis, which promotes host resistance
to infection (38–40). In contrast to this, virulent M. tuberculosis
strains suppressM apoptosis and instead triggerM to undergo
necrosis (41, 42), allowingmycobacteria to evade and spread. The
recent finding that heme causesM cell death with characteristics
of programmed necrosis (24) is consistent with our observation
that heme is cytotoxic toM. avium-infected M (Fig. 6A and B),
which underlies the increase in mycobacterial growth (Fig. 6C).
Furthermore, we show that this mechanism can occur in vivo, as
observed during Mycobacterium infection in Hmox1-deficient
mice (Fig. 3 and 7). Uninfected Hmox1/ mice did not show
increased programmed cell death (Fig. 5). It could be argued that
the infection per se induces M to undergo programmed cell
death. However, in the absence of infection, heme can trigger M
programmed cell death (24) (Fig. 6).
The erythrocyte life span is reduced during anemia in chronic
disease (43), a condition occurring during mycobacterial infec-
tions (44). Moreover, mice infected with Mycobacterium leprae-
murium have increased erythrophagocytosis (45), implying a
higher hemoglobin turnover and supporting the hypothesis that
M are exposed to hemoglobin and therefore to heme during
mycobacterial infection. In the case of HO-1 deficiency, heme is
not adequately cleared, resulting in oxidative damage and pro-
grammed cell death. Heme-driven M programmed cell death
should occur predominantly in M that recognize mycobacteria,
based on the production of reactive oxygen species and TNF in
response to mycobacteria (24). Presumably this explains why
heme catabolism byHO-1 is required tomount a protective gran-
ulomatous response, a notion supported by two independent and
complementary observations. First, granulomas are absent or sig-
nificantly decreased in Mycobacterium-infected Hmox1-deficient
mice, in contrast to wild-type controls, where these structures are
observed (Fig. 3). Second, granuloma formation after M. avium
infection in wild-type mice is drastically reduced by the adminis-
tration of heme (Fig. 6). This suggests that the substrate of HO-1
activity, i.e., heme, impairs granuloma formation and/or mainte-
nance, thus explaining why heme catabolism by HO-1 promotes
granuloma formation and/or maintenance.
The molecular mechanisms regulating granuloma formation
in response toMycobacterium infection are not completely under-
stood (46). It is clear, however, that expression of cytokines, e.g.,
TNF, IFN-, or IL-12, as well as adhesion molecules, e.g.,
ICAM-1, is required for the formation of protective granulomas
(7, 9). The observation that the expression of these genes was not
impaired inM. avium-infectedHmox1-deficient versus wild-type
mice (Fig. 2) suggests that the mechanism via which HO-1 pro-
motes the formation and/or maintenance of protective granulo-
mas acts independently of a putative effect on the expression of
these and probably other related inflammatory genes.
How the absence of granulomas in Hmox1/ mice affects
their resistance to the infection is not clear. The granuloma is
thought to be protective to the host, by favoring a close contact
between infected M and lymphocytes, and the lack of granulo-
mas is usually associatedwith increased bacterial proliferation (7).
Hence, the increased susceptibility of Hmox1/ mice could be
attributed to their inability to form these lesions. However, heme
administration to BALB/c mice blocks the assembly of the granu-
loma, as assessed at day 16 after M. avium infection, without af-
fecting bacterial growth (Fig. 6), whereasHmox1/mice already
have significantly higher bacterial loads at this time point (see Fig.
S1 in the supplemental material). One possible interpretation is
that the lack of granulomas is not entirely responsible for the in-
creased susceptibility ofHmox1/mice, at least during the initial
phase of infection. Similar observations have been made using
Icam-1-deficient mice, which present a deficient recruitment of
M to infected tissues. These mice do not form the granulomas
after aerosol challenge with M. tuberculosis but are capable of
mounting a Th1 cell-mediated response, with normal levels of
IFN- and IL-12, which controls the infection until day 90 simi-
larly to the case for wild-type mice (47). However, at 100 to 130
days after infection, ICAM-1-deficient mice undergo a surge in
bacterial numbers, resulting in lung tissue damage and death (48),
which suggests that although they are not necessary to control the
infection initially, granulomas are necessary to control chronic
infection. Our results show that Hmox1/ mice have increased
bacterial loads after 60 days of infection with M. tuberculosis,
which are probably not attributable to a deficient granuloma for-
mation. However, akin to Icam1/ mice, Hmox1/ mice in-
fected with M. tuberculosis undergo a surge in bacterial numbers
before the death of the host (Fig. 7), corroborating the notion that
the faulty assembly of granulomas may impair the control of in-
fection at late stages.
In addition to acting as a cytotoxic agonist, heme is a putative
source of labile iron that can promote microbial growth, thus
limiting host resistance to infection (49). Hmox1-deficient mice
accumulate heme in plasma and develop tissue iron overload fol-
lowing M. avium infection (Fig. 4A), which could contribute to
the higher pathogen load observed in Hmox1/ than in
Hmox1/mice (Fig. 1D). However, iron overload per se is asso-
ciated with at most a 10-fold increase in pathogen load (50–53),
but Hmox1 deficiency and heme accumulation in plasma are as-
sociated with 100-fold increase in pathogen load, compared to
that in wild-type mice (Fig. 1D). This suggests that HO-1 reduces
the pathogen load by additional mechanisms, other than control-
ling iron overload, presumably through its cytoprotective effect
exerted on infectedM. It should be noted that while exogenously
administered heme inhibits granuloma formation, this is not
enough to cause a significant increase inM. avium growth in vivo
at early infection time points (Fig. 6D and E). Only in the absence
of the protective action of HO-1 does heme cause massive M
death and concomitant uncontrolled bacterial growth.
Although the underlying mechanism via which HO-1 confers
host protection against Mycobacterium infection is similar to the
one described for other pathogens (16, 18, 19), i.e., cytoprotection
against heme, HO-1 confers resistance rather than tolerance to
Mycobacterium infection. The reason for this ismost probably that
HO-1 provides cytoprotection in a major cell compartment con-
ferring resistance to Mycobacterium infection, i.e., M. These
findings should have implications for our understanding of the
pathogenesis of diseases triggered by intramacrophagic pathogens
that have evolvedmechanisms to subvert theM cell death for their
advantage, such as Listeria monocytogenes, Salmonella spp., Shigella
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spp., andYersinia pestis (54–56). Akin to the case forMycobacterium,
HO-1maydetermine thepathological outcomeof these infectionsby
virtue of its cytoprotective effect exerted onM.
There are most probably other mechanisms via which HO-1
controls host microbe interaction in the context of mycobacterial
infection. Carbon monoxide produced via heme catabolism by
HO-1 induces the expression of the dormancy regulon duringM.
tuberculosis infection in vitro (27, 28), suggesting that HO-1 activ-
ity may contribute to latency. Therefore, reduced carbon monox-
ide should prevent the induction of the dormancy regulon, con-
tributing to the increased proliferation of mycobacteria. While
this hypothesis remains to be tested, M. tuberculosis deficient in
the induction of the dormancy regulon establishes in vivo infec-
tions in mice that are indistinguishable from those caused by the
parental strain (57) or even present a growth defect (58), suggest-
ing that a putative effect of CO on the dormancy regulon should
have a limited impact on bacterial growth in vivo.
While we were preparing this article, Regev et al. (32) reported
thatHmox1/mice infected through the intratracheal routewith
M. avium fail to develop organized granulomas in the lung. Those
authors attributed this effect to an increased expression of CCL2/
CCR2 in HO-1 deficient mice, which while consistent with our
findings (Fig. 2; see Fig. S2 in the supplemental material) may be
attributed to a higher bacterial load in Hmox1/ than in
Hmox1/mice, thus inducing CCL2 expression (59). However,
it is not clear whether there is a causal effect of increasedCCL2 and
lack of granulomas. While our present data confirm that HO-1
regulatesMCP-1/CCL2 expression in response toM. avium infec-
tion (Fig. 2; see Fig. S2 in the supplemental material) (32), this
should not have a major impact on pathogen clearance since
MCP-1/CCL2-deficient mice are indistinguishable from wild-
type mice in their ability to clear Mycobacterium infection (60).
Instead we propose that it is the oxidative stress induced by the
accumulation of heme in M that recognize mycobacteria that
inhibits granuloma formation. This argues for the existence of an
inverse relationship between the levels of reactive oxygen and ni-
trogen species and granuloma development, a notion is strongly
supported by our previous observation that inducible nitric oxide
synthase-deficient mice form larger and denser granulomas in re-
sponse to M. avium infection than wild-type mice (33, 61). Of
note, whenwe treatedmice with heme, although they were unable
to form granulomas in response toM. avium infection, the level of
expression ofCcl2mRNA in the liver was not increased compared
to that in control mice (data not shown).
In conclusion, we demonstrate that expression of HO-1 is
strictly required to prevent M from undergoing programmed
cell death induced by free heme, thus playing a key role in host
resistance against mycobacterial infections. We propose that
pharmacologic targeting of heme catabolism might be used ther-
apeutically againstMycobacterium infection.
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